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Abstract
As measles virus causes subacute sclerosing panencephalitis and measles inclusion body encephalitis due to its ability to establish human
persistent infection, without symptoms for the time between the acute infection and the onset of clinical symptoms, it has been the paradigm
for a long term persistent as opposed to chronic infection by an RNA virus. We have reviewed the mechanisms of persistence of the virus
and discuss specific mutations associated with CNS infection affecting the matrix and fusion protein genes. These are placed in the context of
our current understanding of the viral replication cycle. We also consider the proposed mechanisms of persistence of the virus in replicating
cell cultures and conclude that no general mechanistic model can be derived from our current state of knowledge. Finally, we indicate how
reverse genetics approaches and the use of mouse models with specific knock-out and knock-in modifications can further our understanding
of measles virus persistence.
© 2005 Published by Elsevier B.V.
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1. The scope of the review
Measles virus (MV) still provides one of the main
paradigms of a long-term persistent infection by an RNA
virus due to its involvement in the disease subacute scleros-
ing panencephalitis (SSPE), a progressive fatal neurological
disease caused by high levels of neuronal infection by MV in
the central nervous system (CNS). Hence, there has always
been an interest in studying the underlying mechanisms of
MV persistence. Initially, in the late 1960s and the 1970s,
this was studied using cell cultures. However, with the advent
in the 1980s and early 1990s of cDNA cloning and sequenc-
ing technology it became possible to examine virus genomes
present in autopsy material obtained from the CNS of pa-
tients. This review will briefly recapitulate the main findings
of the earlier studies and will then concentrate on setting out
what has been found since the early 1990s. It will illustrate
the utility of reverse genetic approaches and transgenic mouse
studies and show how these, in the future, may further our
understanding of viral persistence in a mechanistic sense. To
date no study has been able to explain why the virus is able
to persist. As such we use this review to highlight the most
pertinent questions which remain to be addressed.
2. Subacute sclerosing panencephalitis and measles
inclusion body encephalitis
The main impetus for the study of MV persistence has
come from the discovery that MV was the cause of SSPE,
a human CNS disease that manifests itself long after the
acute infection with the virus. MV infection is associated
with neurological complications in a small minority of cases.
About 1:1000 cases will suffer post-infection encephalitis,
which involves mainly perivascular demyelination (Litvak et
al., 1943). This often fatal complication appears to be au-
toimmune in nature as no virus can be demonstrated in the
brain of such patients. SSPE has been reported to occur in
1:300,000 cases. However, more recent data suggests that it
is much more prevalent and can follow acute MV infection
in 1:10,000 cases (Takasu et al., 2003). On average, symp-
toms present 8 years after the acute infection, but this ranges
from 9 months to 30 years. Acute infection below the age
of two is a risk factor in this disease, which, as yet inexpli-
cably predominates in males at a 2.5:1 ratio (Halsey et al.,
1980). The disease manifests itself in severe demyelination
and profound infection of neurones. In the latter stages of
SSPE small numbers of oligodendrocytes, astrocytes and en-
dothelial cells have been shown to be affected (Kirk et al.,
1991). This inevitably leads to severe neurological deficits
and death of the patient. One of the longest recorded patients
carried the persistent infection over three decades before the
onset of symptoms. In terms of the duration of the symp-
tomatic period, there is a report of a 52 years old who died
4 years after diagnosis (Tanaka et al., 1987). There is no evi-
dence for a reduction in the cell-mediated immune responses
to MV in SSPE patients. Furthermore, antibody responses
lead to hyperimmunity with extremely high titres of neutralis-
ing antibody in both the serum and cerebrospinal fluid (CSF)
of patients. The CSF contains oligoclonal bands specific to
MV and it has been demonstrated that the antibodies present
in these have undergone affinity maturation (Smith-Jensen
et al., 2000).
In immuno-compromised patients, measles can give rise
to an additional CNS infection, measles inclusion body en-
cephalitis (MIBE) (ter Meulen et al., 1983). In contrast to
SSPE, MIBE is not associated with a hyperimmune antibody
response to measles proteins or oligoclonal bands in the CNS.
Recently MIBE caused the death of a 13-year-old boy who
had been treated for chronic granulomatous disease by stem
cell therapy. Neither the patient nor the stem cell donor had
apparent recent measles exposure or vaccination and neither
had visited a region of the world where MV was endemic
(Freeman et al., 2004). The simplest explanation may be per-
sistence of the virus in either the donor or the recipient. Nev-
ertheless repeat exposure cannot be ruled out in this case as
the virus is highly infectious.
Other suggested sequelae of MV infection are multiple
sclerosis, chronically active autoimmune hepatitis, Paget’s
disease, otosclerosis, Crohn’s disease and autism among
many other diseases (e.g. Reddy et al., 1999). However, no
confirmed evidence has been presented to substantiate these
associations, let alone prove a causative relationship and as
such discussion of these falls outside the scope of this review.
3. MV: the virus and its replication
In order to understand what is known of the molecular
mechanisms of MV persistence it is first necessary to describe
the molecular biology and pathology of MV.
3.1. Virion
MV is an enveloped RNA virus classified in the family
Paramyxoviridae (Griffin, 2001) in the genus Morbillivirus
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Fig. 1. Schematic representation of the virion membrane, genome organisation and the life-cycle of measles virus including the receptors used by the wild-type
and vaccine viruses. Transcription units (TU), and messenger RNAs and proteins are not drawn to scale.
(Fig. 1). The lipid bilayer membrane is derived from the host
cell and is decorated with a fringe of spikes formed by two vi-
ral glycoproteins, the fusion (F) and the haemagglutinin (H)
proteins. In the virion the F (type I) glycoprotein oligomerises
as a homotrimer whereas the H (type II) glycoprotein prob-
ably exists as a tetrameric dimer-of-dimers. The F protein is
formed as an inactive precursor (F0), which is biologically
activated by a proteolytic cleavage involving furin-like pro-
teases (Maisner et al., 2000) to generate the F1 and F2 protein
subunits, which are linked by a single disulphide bridge. In
contrast to some other enveloped viruses, the proteolytic en-
zymes involved are so widespread that biological activation
of the F glycoprotein does not appear to constitute a limit-
ing factor in virus spread. The H and F glycoprotein homo-
oligomers interact with each other to form the biologically
active fusion complex (Wild et al., 1991). After binding of
the H glycoprotein to cell surface receptor(s), it is likely that
a structural change in the F protein is induced which activates
the fusion process but the exact stoichiometry and molecular
details are unknown. The inner leaflet of the virion membrane
is “coated” with a hydrophobic protein called the matrix (M)
protein (Fig. 1). This protein associates with both the short
cytoplasmic tails of F and H and the helical ribonucleoprotein
(RNP) nucleocapsid containing the genome. It plays a role in
the budding of the virus from the plasma membrane.
3.2. Genome organisation
Measles virus RNP is 1m in length and 18–21 nm in di-
ameter (Lund et al., 1984) and consists of the negative sense
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viral genome and at least three associated viral proteins. A
recent study has demonstrated that the virions can contain
more than one RNP (Rager et al., 2002). The genome is a
15,894 nucleotide, non-segmented RNA molecule of nega-
tive polarity (Fig. 1). It contains six transcription units (TUs)
which are separated by non-transcribed intergenic (Ig) se-
quences comprised of three nucleotides. The six TUs are pre-
ceded by a 3′ leader and are followed by a 5′ trailer (Fig. 1).
Morbillivirus genomes are unique within the Paramyxoviri-
dae in that they contain a very long non-coding region of
nearly 1000 nucleotides between the M and F open reading
frame (ORF). The region is GC rich and it is likely to fold
into complex secondary RNA structures. The function of this
region is not well understood. The intergenic sequence be-
tween the M and F genes is placed almost in the middle of
this region.
The complete nucleotide sequence has been determined
for several vaccine and wild-type strains of MV. The genome
encodes at least eight proteins (Griffin, 2001) (Fig. 1). Three
of these, the nucleocapsid (N), phospho- (P) and large (L)
proteins, comprise the transcriptionally active RNP. At least
two further non-structural proteins are generated from the
gene encoding the P protein and as such this gene is some-
times designated P/V/C. The C protein is translated from an
overlapping reading frame and is 186 amino acids in length.
Whilst the function of the C protein is currently unknown,
virus mutants lacking the protein have been propagated suc-
cessfully in tissue culture (Radecke and Billeter, 1996) but
they failed to replicate to a significant level in human thy-
mus implants present in a SCID mouse model and spread
less efficiently in a transgenic mouse model (Valsamakis et
al., 1998). The C protein is suggested to inhibit the type I
interferon response (Shaffer et al., 2003). The V protein is
generated from an “edited” transcript of the P gene (Fig. 1).
It is amino-co-terminal with the first 231 amino acids of the P
protein. Editing involves a process similar to the stuttering on
U tracts at the end of each gene which generates polyadeny-
lated mRNAs (see later). Polymerase stuttering at the editing
site, 3′-YAAUUUUUCCC-5′ (negative sense), leads to the
non-templated insertion of a single G residue in the mRNA
(Cattaneo et al., 1989a,b). The consequent frame switch ac-
cesses an ORF encoding a 69 residue cysteine-rich tail, which
contains a zinc binding domain. This stretch of amino acids
represents one of the most conserved products encoded by
paramyxovirus genomes.
3.3. Virus entry and cell surface receptors
Measles virus attaches to the host cell through the interac-
tion of the viral glycoproteins with cellular receptors (Fig. 1).
The H protein is probably the most important attachment
protein but it is likely that the interaction of the complete
fusion complex with receptors and possibly co-receptors is
required for fusion of the viral envelope with the host cell
membrane. CD46, also known as membrane cofactor pro-
tein, which plays a role in protecting cells from complement
lysis, is a cellular receptor for some laboratory adapted MV
vaccine strains (Do¨rig et al., 1993; Naniche et al., 1993).
In cells infected with these MV strains (but not in those in-
fected with wild-type strains), CD46 is down-regulated from
the cell surface and this renders the cells more susceptible to
complement lysis (Schneider-Schaulies et al., 1995b). Most
wild-type viruses do not use CD46 but instead use CD150
(SLAM) as receptor (Erlenho¨fer et al., 2001; Tatsuo et al.,
2000). Fusion occurs in a pH independent manner at the cell
membrane.
3.4. Transcription, replication, assembly and virus
budding
After fusion of the virion with the cell membrane, the
(−)RNP is introduced into the cytoplasm where it acts as
a template for both primary transcription of mRNAs and
replication of the negative stranded genome RNA into posi-
tive antigenome RNA, which is concomitantly encapsidated
to produce (+)RNP (Fig. 1). It is probable that the viral
RNA-dependent RNA polymerase (RdRp) not only consists
of the P and L proteins but it may also involve unknown host
cell proteins in addition to cytoskeletal components such as
actin and tubulin (Moyer et al., 1990). The RdRp binds to the
promoter sequences in the first 100 nucleotides at the 3′ end
of the genomic RNA. Transcription terminates just before
an intergenic trinucleotide at a gene end (GE) sequence
(Fig. 1). For example, at the end of the N gene the RdRp
encounters a consensus polyadenylation signal sequence of
3′-YAAUA/UNNUUUU-5′ which leads to polyadenylation of
the mRNA by slippage on the U-rich template. The intergenic
sequence (3′-GAA-5′) is not transcribed and transcription
restarts at the 3′ end of the P/V/C gene at a consensus
gene start (GS) sequence of 3′-UCCYNNG/UUYCU/A-5′
(Radecke and Billeter, 1995). These stop/start events are
repeated at the ends of the P, M, F, H and L genes. There is a
finite chance that the RdRp will detach from the template at
each intergenic junction and this gives rise to a gradient of
gene expression in which the promoter proximal genes (i.e.
N and P/V/C) are transcribed much more frequently into
mRNA than the promoter distal genes (i.e. H and L).
During replication the nascent RNA molecule is immedi-
ately encapsidated by N protein and the GE, Ig trinucleotide
and GS signals are ignored. This gives rise to an RNP contain-
ing the positive stranded RNA antigenome molecule. These
have a strong promoter sequence at their 3′ end, which allows
the generation of (−)RNPs. These are transported to the cell
membrane where they associate with viral M protein and the
glycoproteins in lipid raft structures from which the RNPs
bud to form new virus particles.
Development of systems during the last decade which
permit the generation of recombinant MV, “virus rescue”
(Radecke et al., 1995) has opened the door to mechanistic
studies, not only of persistence and the role of specific
genes in this process, but also dissection of the roles of
individual genes in isolation or in combination with others,
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in attenuation, virulence immunosuppression and interaction
with the innate immune system.
4. Studies of MV persistence
Persistent infection in tissue culture cells by RNA viruses
was a well studied topic in the 1960s and 1970s but became
less fashionable, primarily because it was at that stage im-
possible to provide anything more than a description of very
basic culture characteristics such as whether or not the cells
produced virus and if so whether the virus had a mutant phe-
notype. Moreover, the paucity of discernable MV phenotypes
hampered these important studies. Only when the viral pro-
teins were delineated and when cloning and sequencing of the
viral genome had been completed, was it possible to conceive
of studies that would address mechanisms of persistence. Ear-
lier reviews of persistent MV infections in cell cultures (Rima
and Martin, 1976) and in the brain (Rima and Martin 1976;
Schneider-Schaulies et al., 1995a) postulated roles for viral
defective interfering (DI) particles, viral mutants, interfer-
ons, etc. However, no conclusive proposals for mechanisms
for persistence emerged from these.
5. Persistence in cell culture
In this section and the next we review data obtained from
the generation of persistently infected cell cultures and from
sequencing material obtained from SSPE cases. What has
been learnt from these experimental models of persistence
and from clinical material is presented in a unified diagram
(Fig. 2) in order to present the key alterations to the virus
genome, in the virus life-cycle and to the host cell which
have been associated with the persistent state in vitro and
in vivo. When reviewing in vitro studies into persistence by
RNA viruses it is important to distinguish between “carrier”
cultures and “true” persistent infections. In “carrier” cultures
uninfected cells are constantly present due to the existence
of a dynamic equilibrium between virus infected and unin-
fected cells, virus release and cell replication in the culture.
In a “true” persistent culture all cells are infected. “Carrier”
cultures have been considered less relevant as a model for in
vivo persistence of MV.
5.1. Generation of persistently-infected, non-neural cell
lines
Early studies by Rustigian and co-workers (Rustigian,
1962, 1966a,b; Rustigian et al., 1979) and (Minagawa et
al., 1976) demonstrated that it was relatively straightforward
to establish “true” persistent infections with MV in tissue cul-
ture cells such as HeLa cells (Rustigian, 1962, 1966a,b). Oth-
ers used Hep2 cells (Gould and Linton, 1975; McCullough,
1983; Rice and Wolff, 1978), monkey kidney cells (Burnstein
et al., 1974; Crespi et al., 1988; Hummel et al., 1994; Rima et
al., 1977; Wild and Dugre, 1978) or calf kidney cells (Sorodoc
et al., 1980) to produce similar cell lines. Such persistently
infected cell lines were initially established using viruses
derived from the original Edmonston isolate made by John
Enders in 1954. These Edmonston strain derivatives were
propagated many times and adapted to laboratory passage
and form the basis of all MV vaccines. It was clear that
MV could set up persistent infection in many human cell
lines such as human amnion AV3 cells (Rapp and Robbins,
1981), leukocytes (Jacobson and McFarland, 1982; Joseph et
al., 1975) and lymphoblastoid cells (Celma and Fernandez-
Mun˜oz, 1992; Cremer et al., 1979; Fernandez-Mun˜oz and
Celma, 1992; Ju et al., 1980). In general one can draw the con-
clusion that such persistent infections allow the accumulation
of viral mutants, e.g. temperature sensitive mutants, cold sen-
sitive mutants (Rager-Zisman et al., 1984), small plaque mu-
tants or non-syncytial mutants (McCullough, 1983) as well
as mutants that were able to set up persistent infection more
readily than the original virus.
It has always been difficult to study the establishment
phase as often the cultures did not show a consistent
level of infection and underwent crises of cytopathology.
This was especially the case in persistent infections in
which DI particles had been involved and also in those in
which a small number of cells that had survived a lytic
infection were cultured (Rima et al., 1977). A number
of studies were carried out in the 1970s that dealt with
mechanisms of maintenance of stable persistent infections.
Rustigian’s experiments of co-culture of his HeLa cells with
Vero cells to address the nature of the blockage in K11A-
HG-1 cells (Rustigian et al., 1979) demonstrated that the
HeLa cells were infected by a defective MV which upon
introduction into an adjacent Vero cell led to the forma-
tion of non-transmissible transient syncytia formation from
a very small sub-fraction (0.2–0.4%) of the persistently in-
fected cells. Very occasionally transmissible infections de-
veloped after 6–9 weeks from these co-cultures indicating re-
version of the virus to an independent fully-infectious agent.
Whether this involved back mutations is not known. Re-
combination was also proposed as a possible mechanism
for the reversion, but direct evidence for recombination in
non-segmented negative strand RNA viruses is still scant.
The co-cultures were transiently resistant to “superinfection”
by a second equivalent dose of the K11A-HG-1 cells. How-
ever, these studies were limited as superinfection could only
be assessed by the formation of an overt cytopathic effect
(c.p.e.) such as syncytium formation. Interestingly, to this
day the mechanisms involved in superinfection immunity re-
main elusive. Receptor down-regulation has been put forward
an explanation, but usually this is not sufficiently quantita-
tive/complete to explain superinfection immunity on the basis
of blocked entry. Furthermore all cells persistently infected
with vaccine strains of MV are superinfection immune to
vaccine strains of the closely related canine distemper virus
which does not use CD46 (Rima, unpublished; Ludlow et al.,
2005).
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Fig. 2. Compilation of key alterations at the molecular level which have been identified either by sequencing and culturing material derived from SSPE tissue
samples (1) or by generating persistently infected neural and non-neural cell lines (2). Those alterations at the molecular level where studies using SSPE tissue
samples and persistently infected neural and non-neural cell lines have provided equivalent data have also been indicated (3).
The appearance of mutants in persistently infected cul-
tures was first demonstrated by comparison of serum re-
sponses in human convalescent and SSPE sera changes in
patterns of antigenicity of the H protein (Robbins et al., 1991),
N protein (Boriskin et al., 1986), the P or V protein (Bellini
et al., 1986). Reduced amounts of M protein and altered pro-
cessing of the H protein in persistently infected HeLa cell
cultures were shown by difficult pulse-chase experiments
(Young et al., 1985). Later the development of monoclonal
antibodies to the different MV proteins made it much easier
to study mutations and alterations in expression of specific
MV proteins in persistence. Due to the lack of the M pro-
tein in particular, restriction of viral budding was offered as
a mechanism of viral persistence. However, in a persistent
infection of Vero cells with the hamster neurotropic (HNT)
strain of MV restriction in the expression of the fusion pro-
tein was suggested as a mechanism for the maintenance of
persistence (Hummel et al., 1994). The lack of F protein ex-
pression in these cells was attributed to the overabundance
of M/F read-through transcripts (5:1 over F transcripts). Host
factors involved in the control of persistent infection have
been suggested to relate to elements of innate immunity such
as oligo-2′,5′-adenylate synthetase (Fujii et al., 1988, 1990),
interaction with heat shock proteins (Oglesbee et al., 1993)
or altered lipid metabolism in the cells (Anderton et al., 1981,
1982, 1983a,b; Wild et al., 1981, 1986; Wild and Dugre,
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1978). However, in none of these cases has the suggested
mechanism been further investigated. Part of the reasons for
this may be the “perceived” irrelevance of the study of non-
neuronal persistent infection to CNS persistence of MV in
SSPE and MIBE. However, these studies may actually be
highly pertinent if the site of persistence of MV in SSPE is
not in the CNS (see later).
5.2. Generation of persistently-infected, neural cell lines
More effort has been made to establish mechanistic param-
eters in persistently infected cells of neural origin. Persistent
infections have been established in a number of rodent neural
cell lines such as hamster brain cells (Vainionpa¨a¨ et al., 1982),
in C6 rat brain glioma cells (Halbach and Koschel, 1979;
Koschel and Muenzel, 1980) and mouse neuroblastoma cells
(Gopas et al., 1992). Mechanistic studies in the C6 rat glioma
cells demonstrated a loss of function in the endothelin sig-
nalling pathway by loss of its receptor (Meissner and Koschel,
1995; Tas and Koschel, 1991) but this was not functionally
linked to the phenomenon of persistence. The Rager–Zisman
group established a persistent infection in a C1300 neuroblas-
toma cell clone called NS20Y (Rager-Zisman et al., 1984).
These murine cells produced cold-sensitive mutant viruses
and showed an increase in MHC-I expression. They also
showed that a tyrosine residue of the N protein was phos-
phorylated in the persistently infected cells as opposed to
in an acute infection, where only serine and threonine are
phosphorylated (Segev et al., 1995). Many other aspects of
these cells such as transcription regulation; interferon induc-
tion and the expression levels of isoforms of protein kinase C
were investigated (Fishman et al., 1997; Wolfson et al., 1989).
Nevertheless, these studies, which report the most extensive
data on a specific MV persistently infected cell line, do not
provide a coherent mechanistic explanation for persistence
in vitro let alone in vivo. Furthermore the results have not
been confirmed by equivalent experiments in other systems,
for example persistently infected human neuronal cells, and
this makes it at present impossible to use these observations
to provide a generalised explanation of MV persistence.
Since rodents are not natural hosts for any of the known
morbilliviruses studies of persistence and replication of MV
in human cells of neuronal origin are possibly more relevant
to in vivo persistence. Sybille Schneider-Schaulies and her
colleagues have demonstrated differences in MV transcrip-
tion and translation in six human glioma cell lines (D-54, D-
32, U-251, U-105, U-373 and U-138) (Schneider-Schaulies
et al., 1993a,b, 1994). These cells are permissive for MV
replication, but overall levels of transcription and replication
are lower than in equivalently infected HEL or Vero cells.
As mentioned above there is a finite chance that the RdRp
will dissociate from the template at each intergenic junction.
This gives rise to the transcription gradient, which has been
shown to be steeper in rat astroglial cells and in SSPE patient
derived material (see below). Lower relative amounts of the
M, F and H mRNAs are generated compared to the N mRNA
than in acutely infected non-neural cells. However, this effect
on the transcription gradient was only observed in three of
the six cell lines tested (D-54, D-32 and U-251) indicating
that there are cell specific factors that regulate transcription
attenuation in the other cell lines. One such factor may be the
interferon inducible protein MxA. After in vitro differentia-
tion of cells by the treatment with papaverine (a membrane
permeable analogue of cyclic AMP), cells such as D-54 and
U-251 or TE671 (Miller and Carrigan, 1982), showed a se-
lective reduction in the rate of synthesis of MV proteins. In
the case of D-54 and U-251 cells the reduced synthesis was
specific to viral mRNAs as general protein synthesis was not
affected, nor was the translatability of the viral mRNAs af-
fected in vitro. In general these studies showed that in cells of
neuronal origin, cell specific factors and differentiation state
may affect the expression of viral proteins. The relevance of
these observations to mechanisms of in vivo persistence has
not been determined.
5.3. Utilisation of “SSPE” derived viruses
It is important to distinguish between persistently infected
cell cultures which have been established by co-culture of
non-neural cell lines with brain material obtained from SSPE
patients that harbours defective viruses such as the Biken
virus in HEL cells and those set up after infection with so
called “replication competent” SSPE isolates such as the
Halle´, Lec, Mantooth and Horta-Barbosa virus strains. We
have shown earlier that based on their similarity in gene se-
quences to the Edmonston strain the latter most likely repre-
sent laboratory contaminants (Rima et al., 1995) and as such
these cultures are not further discussed here. A number of cell
lines have been established by co-culture such as Lu106 cells,
a human embryo lung fibroblast cell line persistently infected
with a SSPE derived virus, the Biken–Vero cells used by the
Hirano group for a number of studies of persistence mecha-
nisms and a number of cell lines based on MA106 cells.
In the SSPE IP-3-Ca cell line Sheppard et al. (1985)
demonstrated that the defect in viral budding was not due
either to a decrease in the stability of the M gene mRNA or
in the efficiency of its translation. Restriction occurred as a
result of abnormally rapid post-translational degradation of
the M protein. The mechanistic basis of this instability has
never been established. Nevertheless, it provides a reason-
able explanation for the defect in viral replication in the cells
and it correlates with the lack of M expression noted earlier
(Lin and Thormar, 1980). In contrast budding and fusion of
the cells was reduced in HNT-Vero cells and Lu106 cells due
to a restriction in F protein (Hummel et al., 1994; Sheshber-
adaran et al., 1985). In MA SSPE cells (Sheshberadaran et
al., 1985), it was clear that it was a cellular factor that was
important as these cells also failed to form syncytia on acute
infection of the Edmonston virus in the cells. The Biken/HEL
cell line that was derived from co-culture of SSPE brain tis-
sue (Ueda et al., 1975) has been studied extensively. This
persistent infection has been transferred into CV-1 cells by
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co-culture. Sequencing analysis showed that all envelope-
associated viral antigens had undergone mutations which led
to the appearance of novel phenotypes. For example, in the
H protein it was observed that haemadsorption was lost com-
pared to the Nagahata strain, which is the wild-type precur-
sor virus (Breschkin et al., 1979). Delayed activation of F0
was not associated with mutations found at the furin cleav-
age site or the lack of the C terminal pentadecapeptide but
appeared related to mutations in F1 (Watanabe et al., 1995).
However, the main emphasis has been on the study of the
M protein which was shown to be unstable after translation
and to have an eight amino-acid carboxy terminal extension
and 20–22 mutations in the ORF (Ayata et al., 1989; Enami
et al., 1989). The changes were later shown to be associ-
ated with biased hypermutation as they arose from uridine
(U) to cytidine (C) mutations (Wong et al., 1991). The M
protein has been shown not to have the normal RNP bind-
ing activity (Hirano et al., 1993). Reverse genetics was used
to demonstrate that, when this M gene was inserted into the
Edmonston genetic background, the resulting recombinant
virus was infectious in CD46 transgenic mice following in
intracerebral (i.c.) infection. The virus was also able to in-
fect primary neuronal cultures from the transgenic mice in
vitro (Patterson et al., 2001). Interestingly the Biken SSPE
virus appears to out-compete wild-type MV in mixed infec-
tions of CV-1 (Hirano, 1992). Biken virus also out-competed
the Edmonston strain better than the related Nagahata wild-
type strain. Several mechanisms such as the presence of DI
particles, or competition for interacting host or viral proteins
were proposed to explain this. Nevertheless, it is clear that the
resident Biken virus is at a selective advantage which could
explain the accumulation of mutants and the replacement of
wild-type viruses in SSPE. However, the mechanisms were
unfortunately not further investigated.
Biken CV-1 cells do not normally form syncytia (Hirano
et al., 1996). However, fusogenic c.p.e. was inducible by
transfecting the cells with a plasmid DNA expressing hu-
man CD46. Replacing the transmembrane and cytoplasmic
domains of CD46 with a glycosylphosphatidylinositol anchor
did not prevent cell-to-cell fusion but abrogated the normal
receptor down-regulation observed in persistently infected
cells. The down-regulation of CD46 is determined by the
presence of a so called “late domain” (YXXL) in the cy-
toplasmic domain of CD46 (Yant et al., 1997). These late
domains govern interactions with cellular proteins that reg-
ulate degradation and trafficking of proteins within the cell.
Mutations in CD46 that prevented down regulation enhanced
syncytium formation indicating the role of the delicate bal-
ance between H and CD46 surface expression in controlling
fusion in this system.
6. Persistence in the patient
SSPE has been shown to be caused by a persistent MV
infection (Connolly et al., 1967, 1971). MV specific inclu-
sions are present both in the cytoplasm and nuclei of infected
cells (McQuaid et al., 1993). It is assumed that the intracy-
toplasmic inclusions represent the sites of transcription and
replication. However, the nature of the nuclear inclusions has
not been confirmed. These could be viral RNPs but are more
likely to be complexes of viral N protein which has been
shown to be able to translocate to the nucleus (Huber et al.,
1991). The development of RT-PCR technology has allowed
sequence analysis of amplicons derived from the defective
viruses, which are hallmark of SSPE and MIBE. In general
viral RNA is isolated at autopsy, but some samples have been
derived from biopsy material. Most of the details of the mu-
tations come from sequence analysis of persistent infections
maintained by co-culture with monkey kidney cells or from
direct sequence analysis of RNA extracted post mortem from
the brain of the patients.
6.1. The defective nature of virus in SSPE and MIBE
brains
Both SSPE and MIBE are characterised by mutations,
which render the virus defective. These have been charac-
terised in the 1980s and 1990s. The presence of mutations
that may lead to defective budding are concentrated in the
cytoplasmic tail of the F protein and in the M protein. Early
on it was recognised that the hyperimmune response in SSPE
to MV antigens was directed against all except the M protein.
Defects in the levels of M protein are mediated by a number
of mechanisms and mutations which affect the start codon,
that make the protein unstable, enhance proteolytic degrada-
tion or lead to the generation of nonsense mutations, have
all been identified (Cattaneo et al., 1986, 1989a,b; Hirano
et al., 1993). In other instances some genes show clear evi-
dence of so-called biased hypermutation in which U residues
are changed to C residues (Cattaneo et al., 1988; Wong et al.,
1989). The explanation that has been proposed to mediate this
phenomenon involves the activity of double-stranded RNA-
dependent adenosine deaminase (DRADA) which can act on
double stranded (ds)RNA in replicative or transcriptive inter-
mediates. DRADA has been shown to be present in enhanced
levels in human IMR-32 neuroblastoma cell as compared
to Vero cells (Rataul et al., 1992). However, it is not clear
whether and when these dsRNA intermediates would arise in
the normal infection cycle or if they are produced from col-
lapsed transcription and/or replication processes. DRADA
converts adenine to hypoxanthine and in subsequent replica-
tions this forms base pairs with U or C leading either to rever-
sion or to a U→C mutation in the positive strand sequence,
when dsRNA is generated transiently during transcription.
Alternatively, if antigenome replication collapses an A→G
mutation could result in the positive strand. The H gene of IP-
3-CA SSPE virus is hypermutated and contains A→G muta-
tions (Cattaneo et al., 1989a,b) and we have observed that by
cloning a large number of M mRNAs from different areas of
the brain of a particular SSPE patient (case B) that at least five
distinct hypermutation events had taken place to give a hierar-
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chy of more and more mutated M genes (Baczko et al., 1993).
Whether the transcription of the M gene is different or if it is
especially susceptible to biased hypermutation events is not
known. It is more likely is that the process occurs frequently
but that such events in other viral genes generate genomes
that are unfit and counter-selected. There is only one paper
reporting the possible presence of DI particles in SSPE brains
(Sidhu et al., 1994). They have been shown to be present
in measles vaccines (Bellocq et al., 1990) but it is unclear
whether their presence affects the phenotype of the virus.
One further unexplored finding in MV persistence in cell
culture and SSPE that is mirrored in cell culture studies into
persistent infections using other paramyxoviruses, is a high
degree of self-hybridisation when genome length RNA ex-
tracted from cultures or brain material was analysed (Hall and
ter Meulen, 1976). This has been interpreted as indicative of
a higher ratio of antigenome to genome RNP. The potential
mechanism that underlies this observation, e.g. mutations in
the promoters at genome ends have not been explored.
6.2. Altered transcription of measles virus in SSPE
Expression of the M protein can also be reduced by two
transcriptional mechanisms. The first involves the generation
of read-through transcripts of the P and M transcription units.
In at least three SSPE patients, e.g. RNA derived from brain
samples of case K (Cattaneo et al., 1986), and co-cultures
with brain material that established the Yamagata and the MF
cell lines (Cattaneo et al., 1987b) it was found that the RdRp
was unable to recognise the signals in the GE sequences at
the end of the P/V/C gene and GS sequences at the start of
the M genes meaning that all M transcripts were in the form
of P/M read-through RNAs. In these transcripts is unlikely
that a scanning ribosome would get as far downstream as
this to translate the third ORF and thereby synthesize M pro-
tein. Interestingly in both SSPE patients (cases K and MF),
there were no changes in the GE, Ig and GS sequences and
hence mutations leading to the altered properties of the tran-
scriptase complex must lie elsewhere genome. In the case of
the persistent infection with the Yamagata strain, a change
in the intergenic sequence could explain the accumulation of
the P/M read-through RNAs (Yoshikawa et al., 1990). Osaka
viruses have well delineated changes in GS/GE sequences
(Ayata et al., 2002).
The second transcriptional control mechanism affects
the gradient of gene expression. The gradient varies from
one host cell type to another and appears especially steep
in MV infection in the human CNS. For example, in SSPE
the gradient of gene expression is so steep that little F and
H protein is produced, which may aid the virus in escaping
detection by the immune system and would lead to a defect
in budding (Cattaneo et al., 1987a,b). The reduction in
transcripts of the L gene may or may not affect the level of
viral RNA synthesis depending on whether the concentration
of L protein is the rate-limiting step in transcription and/or
replication. The effects of transcription attenuation could
be further enhanced if the respective promoter distal M, F
and H mRNAs were less stable. However, to date there has
been no evidence presented that reports a greater degree of
instability of any specific MV mRNA. On the contrary, all
data, although limited, so far argues for similar half lives of
all viral mRNAs (Ogura et al., 1989).
Hyper-mutation and read-through transcription both lead
to viruses that are defective in M protein expression. Re-
combinant viruses that have the M protein gene deleted are
highly fusogenic and though they are able to penetrate the
brain parenchyma of CD46-expressing interferon / recep-
tor knockout mice deeply after i.c. infection, they cause less
mortality (Cathomen et al., 1998b).
6.3. Mutations in the fusion protein in SSPE and MIBE
Other consistent alterations that occur in all SSPE cases
lead to the loss of the carboxy-terminal pentadecapeptide of
the F protein. This sequence is strictly conserved in all mor-
billiviruses and hence is assumed to have a specific, albeit
as yet unknown function in viral budding. This region con-
tains a tyrosine residue shown to be important as a basolateral
sorting signal (Maisner et al., 1998) and it is also assumed
that the cytoplasmic tail of F is involved in targeting the pro-
tein to lipid rafts and interaction with the M protein. This
was confirmed by generating a recombinant MV which has
the F and H proteins replaced by the G protein of vesicular
stomatitis virus (Spielhofer et al., 1998). The resulting viri-
ons did not contain the M protein, illustrating that the protein
is not absolutely required for virus assembly, although vi-
ral titres were significantly reduced. Viruses that lacked the
F protein tail were found to be very fusogenic in cell cul-
ture. Cathomen et al. constructed recombinant viruses that
had deletions in both the F and H tails and tested these in i.c.
infection of transgenic CD46-expressing interferon / re-
ceptor knockout mice (Cathomen et al., 1998a). Similarly to
viruses that expressed no M protein, these “tailless” mutants
were found to be less lethal than the standard virus and to
penetrate more deeply in the brain parenchyma (Cathomen
et al., 1998b). Mutations that remove the conserved pentade-
camer include the introduction of premature stop codons as
well as frame shift mutations that lead to carboxyl-terminally
extended or truncated F proteins. Deletion of a specific A nu-
cleotide has been observed in a number of cases (Schmid
et al., 1992). Mutants and wild-type sequences have been
found in the same brain. The mechanism of this deletion is
not known but it could be similar to that observed in human
respiratory syncytial virus where deletions in stretches of A
residues can alter the reading frame for the G protein leading
to large scale differences in immunoreactivity of the protein
(Garcia-Barreno et al., 1994).
6.4. Only wild-type virus sequences have been found in
SSPE
Measles virus is a monotypic virus and the virus exists as a
single serotype. Infection with one strain of measles appears
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to provide life-long protection from the disease. With the de-
velopment of RT-PCR and DNA sequencing techniques it has
become clear that virus isolates vary in their nucleotide se-
quences especially in those encoding the last 150 amino acids
of the N protein and the entire H protein (Rima et al., 1997;
Rota et al., 1992, 1994; Taylor et al., 1991). During the last
decade sequences of over 250 strains have been determined
and these show that at least 21 genotypes exist which belong
to eight different groups or clades. Although these viruses
may once have been geographically restricted in their distri-
bution, the increase in travel by children, who are the prime
reservoir for virus replication, has now allowed worldwide
distribution of most of the genotypes. Some of the clades ap-
pear to be extinct as no recent isolates have been made, but it is
difficult to be certain about this as global measles surveillance
is inadequate. In the USA and the UK, it has been possible to
link the origin of the imported strain with travel by specific
index cases (Rota et al., 2004). Thus the different genotypes
have made it possible to establish transmission chains for a
number of outbreaks.
The description of specific clades and genotypes of MV
has allowed the evaluation of mutations found in the MV
RNA sequences from SSPE brain material against wild-type
(clades B–G) viruses. All the vaccine viruses are derived from
the Edmonston strain (clade A) but no clade A virus has been
found in SSPE brain material. The sequences found in SSPE
brain are related to the wild-type viruses circulating at the
time of initial infection of the child and not to those circulat-
ing at the time of onset of symptoms. Hence, the virus which
initially infected the child, appears to persist and SSPE is not
due to a super-infection by viruses circulating during the on-
set of symptoms (Jin et al., 2002; Rima et al., 1995; Rota, per-
sonal communication). To the best of the authors’ knowledge
no vaccine virus, genotype A, sequences have been obtained
from SSPE cases. SSPE has been vastly reduced in incidence
after successful control of measles by vaccination (Dyken et
al., 1989). In contrast, vaccine strains have been identified in
MV infections in immuno-compromised patients who died
from MIBE (Bitnun et al., 1999) and giant cell pneumonia
(Mawhinney et al., 1971).
7. In which tissues does measles virus reside before to
onset of symptoms of SSPE?
Detection of MV RNA in the CNS of SSPE and MIBE
cases is pathognomonic and without exception. However, the
question has been raised as to where the virus persists in the
patient prior to the onset of symptoms. Brown et al. (1989)
documented finding MV in CNS and peripheral tissues ob-
tained from SSPE patients by immunostaining for protein and
in situ hybridisation for RNA. This study used the same in
situ MV probe that was used by Fournier in his studies (Basle
et al., 1986). It should be noted that this probe has been used
extensively in both initial and ongoing in situ hybridisation
studies of a variety of diseases, for example Paget’s disease.
However, in none of the diseases have the results been con-
firmed by others and the fact that 70% of leukocytes were
infected with MV in SSPE patients is at variance with all
other data (Schneider-Schaulies et al., 1991). The most com-
prehensive search for the presence of MV virus outside the
brain is reported in the Brown et al. study (1989). However,
no clear picture emerges from this study as the findings vary
between the cases to case and the results of in situ hybridi-
sation and immunocytochemistry give are inconsistent. Sev-
eral laboratories have examined other tissues isolated from
SSPE patients and have not been able to find evidence of
MV outside the brain. None of these studies have been re-
ported in the literature due to the well-known bias against
the publication of negative results. There is no question that
SSPE is caused by persistent MV infection and it has been
generally assumed that MV resides in the CNS before the
onset of symptoms. However, there is no direct evidence to
support this hypothesis. It would be difficult to obtain con-
clusive evidence either way, as these studies are made post
mortem, hence represent late stages of the disease and there-
fore cannot answer questions about the site of persistence
before the onset of symptoms. Once again this emphasises
why in vitro studies in non-neural cell lines are still very
useful. The fact that in MIBE there are all the hallmarks of
MV hypermutation and spread of the virus over the entire
brain but with a much shorter symptomless period between
the acute infection and the manifestation of CNS infection
could be seen as an argument against the persistence of MV
in the CNS in SSPE cases. It appears that once the virus sets
up neuronal infection it is difficult to stop and even though
there is large variation in the length of time between onset of
symptoms and death in SSPE, it is invariably fatal. Thus it is
the level of the replication in the periphery that might be the
controlling factor that determined the length of symptomless
persistence. The alternative explanation may be that the virus
has been in the CNS all along but has been controlled by the
immune system. Until recently it was assumed that the CNS
was subjected to no or at least lower levels of immune surveil-
lance than many other organs and hence was a place where
a virus such as measles could maintain itself, even though as
an RNA virus it requires constant gene expression and low
level replication in order to persist, which would, in any other
tissue make it visible to the immune system. It is now clear
that the CNS is under immune surveillance (McGavern et al.,
2002). At one time the life-long immunity to measles virus
demonstrated in Panum’s island studies of 1846 was consid-
ered to be evidence for life-long persistence of the antigen
(Panum, 1938). However, it is difficult to accept life-long
persistence of measles virus RNA or protein in the absence
of viral replication and low level gene expression. Indeed in-
tracellular non-replicating MV nucleocapsids are inactivated
within 3 days (Mottet et al., 1990). Hence the life-long immu-
nity was considered evidence for viral persistence and SSPE
cases might have been considered to occur whether the nor-
mal mechanisms to check this persistent infection had broken
down. However, with the discovery of slow cycling memory
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Fig. 3. Immunoreactivity and autofluorescence in primary mouse neurones infected with a recombinant measles virus which expresses EGFP and the H protein of
a rodent-brain adapted strain of MV (CAM/RB). Cells were infected with the virus at a multiplicity of infection of 0.01. Cells were fixed using paraformaldehyde
and examined by confocal scanning laser microscopy for autofluorescence and immunoreactivity. Photomicrographs represent an 8–10m composite optical
section. Images were obtained in double excitation mode. The MV H glycoprotein (red) was detected and visualised by indirect immunofluorescence using a
monoclonal antibody and a CY3 secondary antibody whilst EGFP (green) was detected by virtue of its autofluorescence. Two representative interconnected
cells are shown. (A) EGFP autofluorescence, (B) H glycoprotein and (C) EGFP/H overlay. Magnification ×40.
CD8+ T cells it is no longer necessary to invoke the idea that
life-long immunity equates to viral persistence (Wherry and
Ahmed, 2004).
8. Is there a speciﬁc brain receptor for measles virus?
The role of the currently identified receptors in the spread
of MV within the brain of SSPE patients is unclear. CD46
has not been detected on a differentiated neuronal cell line
(McQuaid et al., 1998) and it has been shown that the virus can
spread between contacting hippocampal neurones in the ab-
sence of CD46 expression and without extracellular virus pro-
duction (Lawrence et al., 2000). The utility of recombinant
viruses which express fluorescent proteins is evident in stud-
ies which aim to investigate the mechanism of MV cell-to-cell
spread in vitro and a MV which expresses enhanced green flu-
orescent protein (EGFP) from an additional promoter prox-
imal transcription unit has been used to infect astrocytoma,
oligodendroglioma and neuroblastoma cell lines (Duprex et
al., 1999b, 2000; Plumb et al., 2002). The recombinant MV
(MVeGFP) has also been used to infect ex vivo hippocampal
brain slices in which the virus was observed to spread unidi-
rectionally, in a retrograde manner from CA1 to CA3 pyra-
midal cells and from there to the dentate gyrus (Ehrengru¨ber
et al., 2002). MVeGFP has also been used to infect CD46-
expressing interferon / receptor knockout transgenic mice
by the i.c. route. Animals showed clinical signs of infec-
tion and EGFP was detected in discrete focal regions of the
brain, in ependymal cells and neuroblasts and deep into the
parenchyma (Duprex et al., 2000). Molecular determinants of
neuropathogenesis have been mapped by generating a recom-
binant virus which expresses a rodent-brain adapted H glyco-
protein in an Edmonston vaccine background (Duprex et al.,
1999a). We have recently generated an equivalent virus which
expresses EGFP (Duprex et al., unpublished) and have been
able to infect dissociated non-transgenic mouse neurones in
vitro. It is clear that this virus can spread transneuronally in
the absence of CD46 in these cultures, reinforcing the sug-
gestion that there are MV neuronal receptors. Furthermore,
it is clear that although H is predominantly localised in the
neuronal cell body it can also be detected in the long intercon-
necting axonal processes (Fig. 3). Collectively, these results
suggest that the virus spreads transneuronally although this
has not been formally proven. Recombinant viruses which
expresses EGFP within the L protein (Duprex et al., 2002)
or at the carboxy terminus of the P protein (Devaux and
Cattaneo, 2004) of MV could help resolve this question as
these viruses permit the visualisation of RNP.
9. Future perspectives
Forty years after the initial electron microscopy studies
(Tellez-Nagel and Harter, 1966) and the identification of the
link between MV and SSPE (Connolly et al., 1967; Payne
et al., 1969) it is clear that much has been learnt about the
plethora of alterations which occur in the genome which
drive the virus to an intracellular existence. As such MV
exemplifies long-term persistence of an RNA virus which
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must continually replicate in the host and also evade immune
detection. Nevertheless, many questions remain unanswered.
Now that SLAM has been identified as a MV receptor, and
since SLAM expression appears to be limited to dendritic
cells and activated T and B lymphocytes as well as monocytes
(Minagawa et al., 2001) two new questions arise. First: how
does the virus transfer from the cells of the lymphoreticular
system to the CNS, endothelia and epithelia? In vitro persis-
tent infection models in SLAM expressing cells may help us
gain understanding of this process. The second question is:
how do cells of the lymphoreticular system enter the CNS?
A Trojan horse mechanism has been proposed for the related
morbillivirus canine distemper virus (Appel et al., 1981) and
since it is now accepted that lymphocytes and macrophages
traffic into the CNS, such a mechanism would no longer be
controversial or problematic. The studies reviewed here also
show that host factors play a role in the maintenance of MV
persistence. In terms of CNS infection these may simply
reflect the fact that neurons are less prone to generate innate
immune responses so as to avoid cytotoxicity due to the
generation of an inflammatory cytokine milieu in the CNS.
Some very basic questions also remain about the cell biol-
ogy of a MV infection in the neuron in SSPE. If microfusion
occurs at the synaptic membrane and if this involves an inter-
action between viral glycoproteins and receptors then what
are the receptors and are both H and F involved; are there spe-
cific fusion receptors; how do the viral glycoproteins localise
to the synaptic membrane; does this involve local protein syn-
thesis, or are excretory vesicles containing viral glycoprotein
transported to the synapses in a retrograde or anterograde
pathway, using dynein or kinesin? It is unlikely that glyco-
proteins traffic from the cell membrane of neuron cell body
along the axonal membranes to the synapse by simple dif-
fusion. These questions are now answerable, at least in part
by combined in situ hybridisation and immunocytochemistry,
for cellular and viral proteins using multicolour fluorescent
probes and viruses which express fluorescent proteins.
Finally, it is clear from the recent report on the genera-
tion of MIBE in a stem cell recipient (Freeman et al., 2004)
that we need to take cognisance of the existence of persis-
tent viruses when such medical interventions are performed.
Another example of this is the potential difficulties porcine
endogenous retroviruses (PERVs) may cause in xenotrans-
plantation approaches (Magre et al., 2003). Indeed, widening
this argument, it is clear that there are many viruses which
have yet to be identified thus continuing to dissect the molec-
ular mechanisms of MV persistence may help if and when
such agents are identified.
10. Conclusions
Much has been learned about mutations that accumulate
during persistence especially in SSPE but it has not been
possible to assess the functional significance of these muta-
tions. New approaches using reverse genetics will now allow
us to introduce selective mutations in vaccine and wild-type
viruses and to assess whether they alter the phenotype of the
virus in such as a way as to aid persistence of the virus.
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